Drawing for STRIATE+

USPTO serial 79308964

STRIATE+

Reviewed by CopyMark Law Group

Reg. 6624450Status 700Registered
Filing date
Status date
Registration date
Jan 25, 2022
Examiner
SAUNDERS, ANDREA DAWN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with STRIATE+?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Matthew J. Stark

Matthew J. Stark Price Heneveld LLP695 Kenmoor Avenue SEGrand Rapids, MI 49501UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Stem cells for medical purposes; collagen for medical use; surgical biodegradable implants being living cells and implantable scaffolds comprising biological materials for use in guided tissue regeneration; surgical implant materials being living cells and implantable scaffolds comprising biological materials for use in guided tissue regeneration; surgical implantable materials being living cells and implantable scaffolds comprising biological materials for use in guided tissue regeneration; surgical implants comprised of living tissues; therapeutic agents for tissue regeneration; therapeutic biological products namely biological cell cultures for medical purposes; medical preparations namely medical preparations for tissue regeneration; guided tissue regeneration materials namely materials for the regeneration of bone and soft tissue; biological preparations for medical purposes for use in guided tissue regeneration for tissue repair; tissue-regenerative medical preparations for use in regeneration of damaged bone tissue; tissues for medical use being living cells; implantable collagen based scaffolding comprising biologically derived collagen for biomechanical support and stabilisation; cellular therapeutic tendon and cartilage regeneration products, namely, preparations comprising cells for the regeneration of bone and soft tissueACTIVE—
010Medical implants made of artificial materials; orthopaedic implants made of artificial materials; surgical implants comprised of artificial materials; dental implants; biodegradable bone fixation implants; surgical implants comprised of artificial materials for use in guided tissue regeneration; surgical implants comprised of artificial materials for replacing human tissue; surgical prostheses namely surgical prostheses for replacing bone and soft tissue; artificial skin for surgical purposes; surgical implants for use in human medicine in the nature of implants made of synthetic materials for use in the regeneration of bone and soft tissue; orthopaedic materials namely synthetic materials for use in the regeneration of bone and soft tissue; orthopaedic implants made of artificial materials; artificial materials for use in guided tissue regeneration namely implantable scaffolds comprising artificial materials for the regeneration of bone and tissue; artificial replacement materials for human tissue namely synthetic collagen based scaffolding materials; replacement materials for animal and human tissue namely synthetic collagen based materialsACTIVE—
044Advisory services relating to medical services; medical services; medical health assessment services; provision of medical information; therapy services being cellular therapy services for the regeneration of bone and soft tissue; physical therapy; medical services featuring biomechanical and cellular therapeutic medical techniquesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 1, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 8, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 7, 2022FIMPFINAL DISPOSITION PROCESSED—
Apr 25, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 25, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 9, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 9, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 20, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 5, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 29, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 29, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 29, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 7, 2021RFNTREFUSAL PROCESSED BY IB—
May 17, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 17, 2021RFRRREFUSAL PROCESSED BY MPU—
May 14, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 13, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 12, 2021DOCKASSIGNED TO EXAMINER—
Apr 20, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 16, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 15, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance